加入會員 會員登入 聯絡我們English

學術論壇

學術論壇可提供瀏覽者及一般會員閱讀瀏覽學術文章。
您必須為協會會員或專科醫師才可擁有發表文章及討論之權限。
發表人 討論主題 發表時間 討論數
趙宸偉 水蒸氣消融術對不同大小的良性攝護腺增生,術後的下泌尿道症狀改善效果分析 2025/11/26 下午 04:56:59 0
原 文 題  目 Prostate Size and Its Effect on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Improvement After Convective Water Vapor Thermal Therapy
作  者 Owen Lewer, Michael D. Felice, Olivia Copelan, Sarang Janakiraman, Gaurav Pahouja, Amy Wozniak, and Kevin T. McVary
出  處 The Journal of Urology Vol. 214
出版日期 July 2025
評 論

在攝護腺微創手術技術蓬勃發展的當下,患者常會帶著各式對於術式選擇上的疑惑進入診間,除了考量患者需求,後續治療成效也是醫療端所重視的議題。透過本篇的研究分析,水蒸氣消融術後,患者於3個月後幾乎都能看到IPSS的顯著改善,但對於38.5 cc以上之攝護腺肥大伴下泌尿道患者,其IPSS下降速率可能更快於小體積族群,從此一結果中分析,或許小體積族群的下泌尿道症狀,在評估上需要更重視其潛在膀胱及神經問題。

abstract

Purpose:
Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) affect quality of life. Convective water vapor thermal therapy (CWVTT; Rezūm) is a minimally invasive surgical treatment for LUTS/BPH which produces significant improvement of LUTS in men with prostates between 30 cc and 80 cc with minimal de novo sexual dysfunction. However, outcomes across the prostate volume (PV) spectrum are incompletely described. We aim to elucidate the relationship between PV and outcomes post CWVTT in men with LUTS/BPH.

Materials and Methods:
Patients undergoing CWVTT at a tertiary care center were included. The primary outcome was change in International Prostate Symptom Score (IPSS) pre CWVTT compared with post CWVTT between PV tertiles—small (≤38.5 cc), medium (38.5 to ≤55.6 cc), and large (>55.6 cc). Secondary outcome was time to a minimally clinically important difference of 25% decrease in IPSS.

Results:
One hundred seventy-one patients were divided into small (n = 56), medium (n = 54), and large (n = 61) PV tertiles. The change in IPSS preoperatively to 3 months was significant for all tertiles with mean difference of −7.51 (−10.14 to −4.83), −10.12 (−12.71 to −7.53), and −11.72 (−14.14 to −9.29) for small, medium, and large PVs, respectively (P = <.001). In multivariable analysis, having diabetes was associated with increased IPSS after 3 months with average increase (95% CI) of 3.67 (0.23-7.11, P = .037) compared with not having diabetes. The median time (Q1, Q3) to −25% in IPSS for small, medium, and large PVs was 16.1 (12.1, 17.5), 12.3 (7.1, 15.7), and 13.8 (10.8, 16.3) months, respectively. In multivariable analysis, medium PV had significantly increased incidence of 25% decrease compared with small PV (HR [95% CI]: 2.10 [1.19-3.72], P = .011).

Conclusions:
CWVTT results in significant and durable LUTS improvement across the PV spectrum. All PVs experience the same improvement in LUTS post CWVTT. However, medium and large glands may improve more quickly than small glands.

回覆發表 回覆討論主題內容 最後發表
目前尚無任何相關的回覆資料